Contact
Please use this form to send email to PR contact of this press release:
Intiva BioPharma Files a U.S. Patent Application for the Use Cannabinoids for Treating Restless Legs Syndrome
TO:
Jeffrey Friedland
INTIVA BioPharma Inc.
800 497 2915